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the same strain of previous TB episode, it is known as 
relapse. If recurrent TB is not due to the same strain of 
the previous TB episode, it is known as reinfection with a 
different Mycobacterium tuberculosis strain. Studies have 
indicated that the recurrence rates in countries with low 
or medium TB incidence are mainly due to relapse of the 
same strain of TB with which the patient was previously 
infected.[5,8,9]
Among the studies conducted in different parts of the 
world, different recurrence rates have been reported. 
Vree et al. in Vietnam showed that 21 out of 244 (8.6%) 
patients experienced a recurrence of the disease 1‑2 years 
after successful treatment.[10] A study in southern Ethiopia 
reported that 15 out of 368 (4.1%) smear‑positive TB 
patients experienced a recurrence of the disease after 
successful treatment.[11] In another study carried out by 
Crofts et al. in England and Wales, the recurrence incidence 
was reported to be 4.1 in 1,000 person‑years.[12]
INTRODUCTION
Tuberculosis (TB) is one of the main health issues in 
many countries. This disease remains a major source of 
morbidity and mortality worldwide.[1‑4] Recurrence of TB 
refers to a situation where a patient who has received at 
least 6 months of anti‑TB drugs and whose smear or sputum 
culture was negative at the end of treatment develops 
active TB again after successful treatment.[5‑7]  If recurrent 
TB is the regrowth of Mycobacterium tuberculosis due to 
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The incidence of smear‑positive TB in Iran was 6.9‑7.6 per 
100,000 people between 2005 and 2011. The incidence 
of smear‑positive pulmonary TB in Mazandaran in 
2009 was 4.3 per 100,000 people.[13,14] In a study carried 
out by Velayati et al. on multidrug resistant (MDR) TB 
patients, 23 out of 65 MDRTB patients (35%) experienced 
recurrence.[15]
Studying the recurrence of TB in patients is a convenient 
way to evaluate the effectiveness of TB control programs 
and identify patients with the highest vulnerability.[5,12] 
However, it seemed as if the documents and evidences 
related to this subject were inadequate in Iran. Therefore, 
in this study, the recurrence rate of TB after successful 
treatment and its predictors were determined in 
smear‑positive TB patients in Mazandaran Province in 
the north of Iran.
MATERIALS AND METHODS
This study was a retrospective cohort study. The source 
of data was the TB register unit at the Ministry of Health 
and Medical Education, Shahrak‑e‑Gharb, Tehran, Iran. 
The patients followed up in this study were smear‑positive 
TB patients with Iranian nationality who received a 
period of 6 months of treatment with anti‑TB drugs and 
were recorded as treated (who were either cured or had 
completed treatment). These patients were diagnosed 
between 2002 and 2011. The end of follow‑up was 
December 2013. The samples of 1,271 subjects were 
entered into the cohort.
In order to compare the demographic characteristics and 
variables studied between the relapse group and the group 
that did not have relapse, Chi‑square test or Fisher’s exact 
test was used for the categorical variables and independent 
t‑test was used for the continuous normal variables. After 
univariate analysis in order to adjust for confounders, 
multivariate logistic regression was used. All the tests 
were two‑sided and the significant level considered was 
less than 0.05. Analysis was done using SPSS 20 (SPSS 
Inc., Chicago IL).
The present project was approved by the Research 
Deputy of Kerman University of Medical Sciences (Code 
No. 92‑136). The first and the last name of the patients 
were not recorded in the checklist and each patient was 
identified through a number.
RESULTS
The number of the patients followed up in this study 
was 1,271 and majority of them were males (56.2%). The 
mean age of all smear‑positive pulmonary TB patients 
in the cohort was 48.4 ± 20.7 years, the mean age of the 
recurrence group was 48.2 ± 20.1 years, and the mean age 
of the nonrecurrence group was 48.5 ± 20.7 years. The age 
difference between the two groups was not statistically 
significant (P = 0.9).
Out of these patients, 106 patients (8.3%) experienced 
recurrence, out of whom 59 patients (55.7%) experienced 
recurrence within 1‑2 years, 32 patients (30.2%) within 
3‑5 years, and 15 patients (14.2%) more than 5 years after 
successful treatment.
Table 1 shows that the recurrence rate was higher in men 
than in women (8.7% vs 7.9%) and recurrence in the age 
group of 15‑34 years was higher than the age group of 
35‑54 years (9.1% vs 7.8%) and the age group of above 
55 years (9.1% vs 8.1%) and recurrence in patients with 
diabetes was higher than in patients without diabetes (9.2% 
vs 8.2%). But the observed differences were not significant 
in univariate analysis.
The recurrence rate was higher in the patients with 2+, 
3+, or higher sputum smear grading before treatment in 
comparison to those with 1+ and 1‑9 bacilli grading (10.6% 
vs 4.6%), in patients with positive sputum smear at the 
end of the second month of treatment in comparison 
to patients with negative sputum smear at the end of 
the second month of the treatment (17.9% vs 7.1%), in 
patients with completed treatment in comparison to cured 
patients (17.4% vs. 6.8%), and in smokers in comparison 
to nonsmokers (13.4% vs 7.2%). These differences were 
statistically significant in univariate analysis [Table 1].
The results of multivariate logistic regression showed that 
the recurrence rate was more in men than in women and 
more in diabetic patients than in nondiabetics. The results 
for the other variables have been shown in Table 2.
Table 1: The distribution of clinical and demographic 
characteristics of TB patients with relapse and without 
relapse
Variables n n (%) P 
(χ² test)Relapse Without relapse
Total 1,271 106 (8.3) 1,165 (91.7) ‑
Gender
Male 714 62 (8.7) 652 (91.3) 0.34
Female 557 44 (7.9) 513 (92.1)
Age group
15‑34 years 418 38 (9.1) 380 (90.9) 0.78
35‑54 years 334 26 (7.8) 308 (92.2)
≤55 years 519 42 (8.1) 477 (91.9)
Result of sputum smear 
before treatment
1‑9 bacilli and 1+ 475 22 (4.6) 453 (95.4) <0.001
2+ and 3+ 796 84 (10.6) 712 (89.4)
Result of sputum smear at the 
end of 2 months of treatment
Negative 1,126 80 (7.1) 1,046 (92.9) <0.001
Positive 145 26 (17.9) 119 (82.1)
Treatment result
Cured 1,081 73 (6.8) 1,008 (93.2) <0.001
Completed treatment 190 33 (17.4) 157 (82.6)
Diabetes
No 1,086 89 (8.2) 997 (91.8) 0.37
Yes 185 17 (9.2) 168 (90.8)
Smoking
No 1,040 75 (7.2) 965 (92.8) 0.002
Yes 231 31 (13.4) 200 (86.6)
TB: Tuberculosis
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Out of the 102 (8%) cases with smear‑positive pulmonary 
TB and known human immunodeficiency virus (HIV) 
status, only 12 (0.9%) were HIV‑positive. This variable was 
not used in the analysis due to the unknown HIV status of 
the majority of patients who entered the cohort.
DISCUSSION
This study has determined the recurrence rate of 
smear‑positive pulmonary TB patients and some 
of its effective factors. In this study, 8.3% of cases 
of smear‑positive pulmonary TB cases experienced 
recurrence and over half of the recurrent cases emerged 
within 1 year or 2 years after successful treatment. The 
recurrence rate was more in males, those in the age group 
of 15‑34 years, diabetic patients, smokers, patients with 
2+ or 3+ sputum smear grading before treatment, patients 
with positive sputum smear at the end of the second month 
of treatment, and patients with completed treatment (not 
cured).
In a study in Cape Town, Western Cape, South Africa 
that was conducted in order to investigate the recurrence 
rate of TB in patients after treatment, it was found that 
out of 612 patients, 18% experienced recurrence.[16] The 
recurrence rate in the abovementioned study was higher 
than the present cohort. One of the reasons for the higher 
recurrence is the higher incidence of smear‑positive 
pulmonary TB in Cape Town (300 per 100,000 persons) in 
comparison to 4.3 cases per 100,000 persons in the north 
of Iran.[13,16]
Another study carried out in Karakalpakstan in Uzbekistan 
on 118 pulmonary TB patients showed that 42 (36%) 
experienced relapse of TB and the relapse rate in cured 
patients was 31% and in the group that completed 
treatment it was 47%.[17] In a retrospective cohort study 
carried out in Vietnam, 1,068 smear‑positive pulmonary 
TB patients were followed up over an 18‑month period 
and 23 (2.1%) of them experienced relapse.[18] The reported 
recurrence rate is lower than in the present study and the 
reason for this difference is likely related to the follow‑up 
period that was shorter than in the reported studies.
In a study carried out in Yemen on 774 smear‑positive 
pulmonary TB patients, the recurrence rate was in 5.7% 
or 44 cases that was more than in the present study. 
Multivariate logistic regression showed that smoking and 
the existence of cavity and diabetes were associated with 
recurrence but age and sex had no significant relation.[19] 
In a study conducted in India, 458 pulmonary TB patients 
were studied in 2012. It was reported that 66 (14.5%) 
patients had diabetes and the recurrence rate in diabetic 
patients were more than in those without diabetes.[20] 
Gounder et al. indicated that TB patients with diabetes 
experienced more unfavorable outcomes of treatment 
compared to those without diabetes and diabetes increases 
the risk of TB recurrence and death.[21]
Smoking is considered one of the main public health 
problems and is known as a risk factor for pulmonary TB. 
In a study, 2,025 pulmonary TB patients (69.3% smokers 
and 30.3% nonsmokers) were investigated. The recurrence 
rate of TB in smokers was more than in nonsmokers (5% 
vs. 1%) and this result is consistent with the findings of 
the present study.[22]
One of the limitations of this study was that drug sensitivity 
test for the detection of drug resistance was not carried out. 
Additionally, we were not able to separate reinfection 
from recurrence. But it should be mentioned that about 
86% of the recurrent cases experienced a relapse during 
1‑5 years after successful treatment. Another limitation 
of the present study was that it did not investigate 
the relationship between incidence of recurrence and 
coinfection with HIV.
This study showed that a significant percentage of 
smear‑positive pulmonary TB patients experienced 
recurrence of TB after successful treatment. Also, the 
strongest predictors of recurrence were smoking, 2+ and 
3+ sputum smear grading before treatment, positive 
sputum smear at the end of the second month of the 
treatment, and completed treatment.
According to results of the present study, it is recommended 
that the sputum smear of all smear‑positive pulmonary TB 
patients should be investigated at the end of the treatment 
period in order to ensure cure of the patients. Also, there 
is a need to implement the directly observed treatment, 
short‑course (DOTS) in TB patients more effectively by 
choosing motivated and committed supervisors from 
the health personnel. Also, cases in whom the result of 
Table 2: Multivariate logistic regression of factors 
associated with relapse among TB patients
Variables OR* CI** P
Gender
Male ‑ ‑ ‑
Female 1.2 0.7‑1.8 0.52
Age group
15‑34 years ‑ ‑ ‑
35‑54 years 0.7 0.4‑1.2 0.21
≤55 years 0.9 0.5‑1.4 0.61
Result of sputum smear before treatment
1‑9 bacile and 1+ ‑ ‑ ‑
2+ and 3+ 3.2 1.9‑5.4 <0.001
Result of sputum smear at the end of 2 
months of treatment
Negative ‑ ‑ ‑
Positive 2.4 1.4‑3.9 0.001
Treatment result
Cured ‑ ‑ ‑
Completed treatment 4.2 2.6‑6.9 <0.001
Diabetes
No ‑ ‑ ‑
Yes 1.1 0.6‑2.03 0.72
Smoking
No ‑ ‑ ‑
Yes 2.2 1.3‑3.7 <0.001
*OR: Odds ratio, **CI: Confidence interval, TB: Tuberculosis
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sputum smear was positive at the end of the second month 
of treatment, an antibiogram of anti‑TB drugs should be 
done in order to apply appropriate remedial procedures 
as soon as possible.
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